ESMO 2022 Conference Coverage
T

ESMO 2022 Updated Results From ADAURA: Osimertinib as Adjuvant Therapy in Patients With Resected EGFRm Stage IB–IIIA NSCLC

By ESMO 2022 Conference Coverage FEATURING Tom John
By ESMO 2022 Conference Coverage FEATURING Tom John
641 views
November 8, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
11:07
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical…

Feat. J. West
17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
09:40
John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
26:21
Memorial Sloan Kettering Cancer Center

NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…

Feat. M. Hwang
05:02
GRACE

Targeted Therapies in Lung Cancer 2023: Biomarkers in NSCLC

Feat. A. Desai
23:32
2023 West Oncology Conference

2023 Updates on Neoadjuvant and Adjuvant NSCLC

Feat. M. Johnson
17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
20:27
Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst
06:20
Blanca Ledezma

Practical Guidance for the Management of Adverse Events in Patients …

26:42
Total Health

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…

Feat. J. Bauman
17:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Expert Discussion on New Treatment Options…

Feat. D. Carbone, B. Stiles
21:24
Chul Kim

ADCs and Bispecific Inhibitors in NSCLC

23:29
2023 Evolution Conference

IO and Targeted Treatment for mNSCLC

Feat. M. Mooradian
07:38
GRACE

How Does PD-L1 Score Affect Treatment Options for NSCLC

Feat. S. Patel, T. Leal, P. Iyengar, A. Desai, C. Kim, J. Rotow
13:21
Yale Cancer Center

Navigating the Terrain: Recent Treatment Strategies for EGFRm Advanc…

Feat. A. Nassar
17:29
Wenhua Liang

Novel Early Management of Lung Cancer

04:31
Integrity Continuing Education

Neoadjuvant and Adjuvant Treatment in Early Stage NSCLC: Options Are…

Feat. J. Gainor, J. Sands
28:04
OncoAlert

Current Controversies in NSCLC Treatment

Feat. J. West